Seaport Therapeutics, Inc. (SPTX) Cash flow

33 Followers

Seaport Therapeutics, Inc. Cash Flow

SPTX's free cash flow for Q2 2026 was $-26.14M. For the 2026 fiscal year, SPTX's free cash flow was decreased by $― and operating cash flow was $-26.14M. See a summary of the company’s cash flow.

Cash Flow	Dec 25
Operating Cash Flow	$ -77.94M
Investing Cash Flow	$ -184.25M
Financing Cash Flow	$ -873.00K
End Cash Position	$ 46.50M
Free Cash Flow	$ -78.30M

Currency in USD